Citation | DeMong, D; Dai, X; Hwa, J; Miller, M; Lin, SI; Kang, L; Stamford, A; Greenlee, W; Yu, W; Wong, M; Lavey, B; Kozlowski, J; Zhou, G; Yang, DY; Patel, B; Soriano, A; Zhai, Y; Sondey, C; Zhang, H; Lachowicz, J; Grotz, D; Cox, K; Morrison, R; Andreani, T; Cao, Y; Liang, M; Meng, T; McNamara, P; Wong, J; Bradley, P; Feng, KI; Belani, J; Chen, P; Dai, P; Gauuan, J; Lin, P; Zhao, H The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist. J Med Chem57:2601-10 (2014) [PubMed] Article |
---|
SMILES | CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cccc(c1)C(F)(F)F)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:15.19,6.5,wD:12.13,c:10,(29.88,-44.48,;29.86,-42.94,;28.52,-42.19,;28.53,-43.7,;31.19,-42.16,;31.17,-40.62,;32.49,-39.83,;32.44,-38.3,;33.65,-37.35,;35.13,-37.76,;33.12,-35.9,;31.58,-35.96,;31.16,-37.44,;29.97,-36.45,;28.53,-36.98,;28.26,-38.5,;29.45,-39.49,;30.9,-38.95,;26.83,-39.03,;25.64,-38.05,;25.38,-39.57,;26.56,-40.55,;33.9,-34.57,;33.13,-33.23,;33.91,-31.9,;35.45,-31.91,;36.21,-33.25,;35.44,-34.58,;37.75,-33.26,;38.51,-34.6,;38.53,-31.93,;39.29,-33.26,;33.82,-40.62,;33.8,-42.16,;35.12,-42.95,;36.47,-42.2,;36.49,-40.66,;35.16,-39.87,;37.79,-42.99,;37.77,-44.53,;39.13,-42.23,;40.46,-43.02,;41.8,-42.26,;43.2,-42.9,;44.24,-41.77,;43.48,-40.43,;41.97,-40.73,)| |